Applied DNA Sciences Inc (APDN) said it will launch its Linea 2.0 COVID-19 Assay, a new RT-PCR assay for the SARS-CoV-2 E and N genes in the next few days....
Flora Growth (FLGC) on Monday said that it entered into a licensing deal with Tonino Lamborghini to produce and distribute Tonino Lamborghini branded...
Applied DNA Sciences (APDN) signed a mutual collaboration agreement with Ganesha Ecosphere, an India-based recycled polyester fiber producer, according to...
Applied DNA Sciences (APDN) said Monday it has received purchase orders amounting to $1.6 million from an unnamed textile customer for the supply of...
| Address | 50 Health Sciences Drive Stony Brook, New York 11790 |
| Phone | +1.631.240.8800 |
| Number of Employees | 59 |
| Recent SEC Filing | 11/04/2021 8-K |
| Chairman, President & Chief Executive Officer | James A. Hayward |
| Chief Operating Officer | Judy Murrah |
| Chief Financial Officer & Controller | Beth M. Jantzen |
| Director-Personal Care | Barbara Brockway |
| Price Open | $5.35 |
| Previous Close | $5.40 |
| 52 Week Range | $4.65 - 13.64 |
| Market Capitalization | $39.2 M |
| Shares Outstanding | 7.5 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 12/16/2021 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$2.21 |
| Beta vs. S&P 500 | N/A |
| Revenue | $3.9 M |
| Net Profit Margin | -220.54% |
| Return on Equity | -121.75% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
